Phibro Animal Health (PAHC) Misses Q3 EPS by 4c, FY Guidance Comes in Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Phibro Animal Health Corporation Reports Third Quarter Results
May 6, 2019 4:20 PM EDTTEANECK, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2019.
Highlights for the March 2019 quarter (compared to the March 2018 quarter)
Net sales of $206 million, a decrease of $3 million, or 2%Net income of $15 million, a decrease of $5 millionDiluted EPS of $0.37, a decrease of $0.12Adjusted EBITDA of $30 million, a decrease of $3.4 million, or 10%Adjusted diluted EPS of $0.39, a decrease of $0.07, or 15%Phibro also updated its full year financial guidance, to include:
... More